Exercise and medication for weight loss in women
Part of Hormones & metabolism clinical trials.
This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 50 years old.
- Your body mass index (BMI) is 27 or higher with a weight-related health issue, or between 30 and 35.
- You have not taken GLP-1 medications before (like Wegovy, Ozempic, or Mounjaro).
- You do not have diabetes (type 1 or 2).
- You are not pregnant, planning pregnancy in the next 6 months, or on hormone replacement therapy.
- You have not done regular resistance training (more than 10 sessions per year) before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of exercise and a weight loss medication (tirzepatide) can help people with overweight or obesity lose weight and improve their health. It's a good fit if you are between 30 and 65, have a BMI of 30–40 (or 27–29.9 with a related health risk), and are generally healthy enough for medication and exercise.
This study tests whether a 12-week program of exercise and personalized nutrition counseling can help obese adults maintain muscle and bone while taking GLP-1 medications (drugs that help with weight loss). GLP-1 drugs can sometimes cause muscle loss, so this trial explores whether targeted exercise and nutrition can prevent that.
This study looks at what happens to your body (especially muscle) when you take a newer weight-loss medication, either with or without adding an exercise program. It could help you understand how to best protect your muscle while losing weight.
This study looks at whether a guided strength-training app can help women in their 40s and 50s who are starting a GLP-1 medication (like Ozempic or Wegovy) build muscle and stay healthy. You'd follow a home-based workout plan for 12 weeks and attend a few in-person visits.
This study tests whether a GLP-1 medication (a type of drug that helps with weight and blood sugar) can improve lung function and muscle strength in people with COPD who are overweight or have weight-related health problems. It may offer a new way to treat both breathing and muscle issues in COPD.
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
Hear when a new Muscle Mass and Strength trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.